Downloads

  1. Development Solutions For Biologics CHO CLD Platforms 6/13/2025

    Aragen offers choice of CLD platforms, efficient Upstream and Downstream process development

  2. Analytical Solutions Laboratory 6/13/2025

    Aragen with a team of experts converge to offer a diverse range of analytical capabilities. With our flexible service models, including Full-Time Equivalent (FTE) and Fee-for-Service (FFS), we tailor our support to your specific needs.

  3. Digitalizing Batch Records In Pharmaceutical Production 6/13/2025

    Pharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. Discover how digital solutions can transform compliance and innovation.

  4. Digital Twins: A Game-Changer Throughout The Pharmaceutical Lifecycle 6/13/2025

    Discover how end-to-end digital twins and Integrated Process Models are transforming pharmaceutical manufacturing to enhance flexibility, accelerate time-to-market, and enable real-time decision-making through MES integration.

  5. Real-Time Monitoring Of Solvent Clearance By TFF In The ADC Process 6/13/2025

    Raman spectroscopy revolutionizes ADC manufacturing by enabling real-time monitoring of solvent clearance. Discover how it enhances process control, ensures regulatory compliance, and supports the production of high-quality therapeutics.

  6. Amgen Bets On Agility In The Age Of AI 6/13/2025

    The company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.

  7. A Single Resource For Total Cleanroom Confidence 6/12/2025

    Discover innovative, pre-engineered modular cleanroom solutions for the pharmaceutical, biotech, and life science industries with a focus on quality and safety that helps your project meet its requirements.

  8. The Role Of Developability In Lead Candidate Selection 6/12/2025

    Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.

  9. Services Designed To Take You From Molecule To Market 6/12/2025

    Accelerate your biopharma journey with a comprehensive service portfolio designed to speed development, reduce costs, and minimize risk from molecule to market.

  10. Peeling Back The Layers Of Radiolabeled Peptide Production 6/12/2025

    From the moment radiolabeled drugs are made, it’s a race to get them to patients. Radioactive decay is just one of many complications. Here’s one company’s approach.